Eli Lilly
LLY
$13.30 (-1.30%)
1D
1W
3M
1Y
5Y
ALL
Eli Lilly and Company is a drug manufacturing company. The Company is engaged in the discovery, development, manufacturing, marketing, and sales of pharmaceutical products across the world. The Company's diabetes products include Baqsimi, Basaglar, Humalog, Humulin, Jardiance, Lyumjev, Trajenta and Trulicity. Its oncology products include Alimta, Cyramza, Erbitux, Retevmo, Tyvyt and Verzenio. The Company's immunology products consist of Olumiant and Taltz. Its neuroscience products include Cymbalta, Emgality, Reyvow and Zyprexa. Its other therapies consist of Bamlanivimab, etesevimab, Cialis and Forteo. The Company manufactures and distributes its products through facilities in the United States, including Puerto Rico, and about eight other countries. Its products are sold in approximately 120 countries. Its subsidiaries include Acanthas Pharma, Inc., Alnara Pharmaceuticals, Inc., ARMO Biosciences, Inc., and Avid Radiopharmaceuticals, Inc., among others.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
CNBC • 2 hours ago • LLY
Eli Lilly accuses church bishops, businessmen of fraud in Trulicity drug rebate scheme
24/7 Wall Street • 1 day ago • LLY
Ditch or Double Down on This Pharma ETF as Trump Adjusts Drug Prices?
Zacks Investment Research • 1 day ago • LLY
Silver Economy Investing: Why the Healthcare Giants Are in Focus
24/7 Wall Street • 1 day ago • LLY
If You Hold This Healthcare ETF, You're Losing Big
Seeking Alpha • 1 day ago • LLY
Eli Lilly Is A Buy (Technical Analysis)
Charts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.